Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72485-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 72485-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7248520101

Packaging label for Azacitidine Injection 100 mg/vial, a lyophilized powder for solution for intravenous and subcutaneous use. The single-dose vial is labeled as a cytotoxic agent and includes storage and safety instructions. Manufactured by Shilpa Medicare Limited in India and distributed by Armas Pharmaceuticals Inc., USA. The label features barcode and lot/expiration date fields.*

FDA Label Image

Graph

A Kaplan-Meier survival curve comparing the proportion surviving over time (months) from randomization for two groups labeled AZA and CCR. The chart includes statistical data such as log-rank p-value, hazard ratio (HR) with confidence interval, and number of deaths in each group. The X-axis represents time in months, and the Y-axis represents the proportion surviving.*

FDA Label Image

Structure

Chemical structure of azacitidine showing its molecular framework including nitrogen, oxygen, and hydroxyl groups as part of the bicyclic ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.